Olga Uspenskaya- Cadoz

Olga Uspenskaya- Cadoz

Company: Prevail Therapeutics

Job title: Vice President, Clinical Development

Seminars:

Q&A Panel Discussion: Addressing Clinical Trial & Regulatory Challenges 3:20 pm

Read more

day: Day One

Optimising Clinical Trial Design for Adult Patient Populations & Neurodegenerative Diseases 3:00 pm

Disease-modifying AAV9-based gene therapies for genetically gefined patient sub-populations suffering from neurodegenerative disorders Choosing the right biomarker-based and clinical endpoints for FIH trials Incorporating patient experience when designing a clinical trial for genetic forms of PD and FTD Executing global FIH AAV9-based trial: challenges and opportunitiesRead more

day: Day One

Q&A Panel Discussion: Highlighting Key Clinical Progress in Gene Therapies for Neurological Disorders 9:20 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.